BioStock: Chordate presents study results for the American Headache Society
The final results from Chordate Medical’s PM007 study show that K.O.S. has a significant effect for the preventive treatment of chronic migraine. The results will be presented at the American Headache Society Scientific Meeting in mid-June and are also available on the organisation’s website.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se